Acurx Pharmaceuticals
Stock Forecast, Prediction & Price Target
Acurx Pharmaceuticals Financial Estimates
Acurx Pharmaceuticals Revenue Estimates
Acurx Pharmaceuticals EBITDA Estimates
Acurx Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $10.34M Low: $10.34M High: $10.34M avg. 0% | Avg: $16.03M Low: $16.03M High: $16.03M avg. 55.03% | Avg: $3.53M Low: $3.53M High: $3.53M avg. -77.95% | Avg: $50.61M Low: $50.61M High: $50.61M avg. 1331.71% |
Net Income
% change YoY
| $-12.68M N/A | $-12.09M 4.64% | $-14.57M -20.56% | Avg: $-25.77M Low: $-29.39M High: $-10.89M avg. -76.77% | Avg: $-16.74M Low: $-43.33M High: $-11.27M avg. 35.03% | Avg: $-21.54M Low: $-21.54M High: $-21.54M avg. -28.68% | Avg: $-12.79M Low: $-12.79M High: $-12.79M avg. 40.58% |
EBITDA
% change YoY
| $-12.88M N/A | $-12.09M 6.11% | $0 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.24 N/A | -$1.12 9.67% | -$1.15 -2.67% | Avg: -$1.59 Low: -$2.32 High: -$0.86 avg. -38.26% | Avg: -$2.16 Low: -$3.42 High: -$0.89 avg. -35.53% | Avg: -$1.7 Low: -$1.7 High: -$1.7 avg. 21.11% | Avg: -$1.01 Low: -$1.01 High: -$1.01 avg. 40.58% |
Operating Expenses
% change YoY
| $12.81M N/A | $12.09M -5.62% | $14.57M 20.54% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Acurx Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -7.45% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -29.39M, average is -25.77M and high is -10.89M.
What is Acurx Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 327.19% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $10.34M, average is $10.34M and high is $10.34M.
What is Acurx Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -3.02% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.32, average is -$1.59 and high is $-0.86.